When should co-ingestants be considered in the differential diagnoses of opioid toxicity?

Updated: Jul 19, 2021
  • Author: Everett Stephens, MD; Chief Editor: Jeter (Jay) Pritchard Taylor, III, MD  more...
  • Print
Answer

Illicit use of narcotics for recreation or the use of methadone for opioid dependence can be associated with co-ingestants including cocaine, benzodiazepines, cyclic antidepressants, [31]  methamphetamine, or other substances. [20] Suspicion of co-ingestants should be nurtured when the patient's clinical course does not conform closely to known opiate effect profiles, especially given the cardiac toxicity of the tricyclics.


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!